CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
Stannous fluoride +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02937636
NCT02937636N/ACompleted
CompareCT.gov

A Clinical Study Investigating the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population.

GlaxoSmithKline·interventional·Posted Oct 18, 2016·Updated Jun 14, 2019

In Brief

A clinical study evaluating Stannous fluoride and Sodium monofluorophosphate for Gingivitis. Completed, enrolled 128 participants across 1 site.

Detailed Summary

This single-centre, examiner-blind, randomized, stratified, two-treatment, parallel group clinical study will evaluate the efficacy of a 0.454% w/w stannous fluoride dentifrice compared to a reference dentifrice to control gingivitis (gingival bleeding and visual signs of gingival inflammation) in dentally and periodontally healthy adult volunteers over 12 weeks use in a Chinese population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGingivitis
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedOct 18, 2016
Enrollment StartSep 19, 2017
Primary CompletionDec 22, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.7 years ago

Interventions

Stannous fluorideother

Experimental dentifrice containing 0.454% w/w stannous fluoride \& 0.0721% w/w sodium fluoride containing1450 parts per million (ppm) fluoride

Sodium monofluorophosphateother

Dentifrice containing 0.14% w/w sodium monofluorophosphate containing1400 ppm fluoride